These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 15337326

  • 1. Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid.
    Namjoshi MA, Risser R, Shi L, Tohen M, Breier A.
    J Affect Disord; 2004 Sep; 81(3):223-9. PubMed ID: 15337326
    [Abstract] [Full Text] [Related]

  • 2. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 3. Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
    Houston JP, Ahl J, Meyers AL, Kaiser CJ, Tohen M, Baldessarini RJ.
    J Clin Psychiatry; 2006 Aug; 67(8):1246-52. PubMed ID: 16965203
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M.
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [Abstract] [Full Text] [Related]

  • 5. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL.
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [Abstract] [Full Text] [Related]

  • 6. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.
    Revicki DA, Paramore LC, Sommerville KW, Swann AC, Zajecka JM, Depakote Comparator Study Group.
    J Clin Psychiatry; 2003 Mar; 64(3):288-94. PubMed ID: 12716270
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acute dysphoric mania: treatment response to olanzapine versus placebo.
    Baker RW, Tohen M, Fawcett J, Risser RC, Schuh LM, Brown E, Stauffer VL, Shao L, Tollefson GD.
    J Clin Psychopharmacol; 2003 Apr; 23(2):132-7. PubMed ID: 12640214
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
    Kulkarni J, Filia S, Berk L, Filia K, Dodd S, de Castella A, Brnabic AJ, Lowry AJ, Kelin K, Montgomery W, Fitzgerald PB, Berk M.
    BMC Psychiatry; 2012 Dec 17; 12():228. PubMed ID: 23244301
    [Abstract] [Full Text] [Related]

  • 11. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I.
    J Clin Psychiatry; 2012 Nov 17; 73(11):1412-9. PubMed ID: 23218157
    [Abstract] [Full Text] [Related]

  • 12. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.
    Am J Psychiatry; 2005 Jul 17; 162(7):1281-90. PubMed ID: 15994710
    [Abstract] [Full Text] [Related]

  • 13. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL.
    Am J Psychiatry; 2006 Feb 17; 163(2):247-56. PubMed ID: 16449478
    [Abstract] [Full Text] [Related]

  • 14. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL.
    J Clin Psychiatry; 2005 Feb 17; 66 Suppl 3():12-9. PubMed ID: 15762830
    [Abstract] [Full Text] [Related]

  • 15. Mood stabilizer augmentation with olanzapine in acutely manic children.
    Chang KD, Ketter TA.
    J Child Adolesc Psychopharmacol; 2000 Feb 17; 10(1):45-9. PubMed ID: 10755582
    [Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of switching to ziprasidone from olanzapine in patients with bipolar I disorder: an 8-week, multicenter, open-label study.
    Lee HB, Yoon BH, Kwon YJ, Woo YS, Lee JG, Kim MD, Bahk WM.
    Clin Drug Investig; 2013 Oct 17; 33(10):743-53. PubMed ID: 23990283
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine versus divalproex in the treatment of acute mania.
    Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, Milton DR, Risser R, Gilmore JA, Breier A, Tollefson GA.
    Am J Psychiatry; 2002 Jun 17; 159(6):1011-7. PubMed ID: 12042191
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis.
    Fajutrao L, Paulsson B, Liu S, Locklear J.
    Clin Ther; 2009 Jun 17; 31 Pt 1():1456-68. PubMed ID: 19698903
    [Abstract] [Full Text] [Related]

  • 19. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression.
    Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I.
    Am J Psychiatry; 2000 Jan 17; 157(1):124-6. PubMed ID: 10618026
    [Abstract] [Full Text] [Related]

  • 20. Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.
    Bowden CL, Myers JE, Grossman F, Xie Y.
    J Clin Psychiatry; 2004 May 17; 65(5):707-14. PubMed ID: 15163260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.